Valuation: West Pharmaceutical Services, Inc.

Market Cap 25.31B 22.12B 20.41B 18.81B 35.46B 2,437B 36.24B 244B 95.95B 1,194B 95.05B 92.96B 4,109B P/E 2026 *
42.6x
P/E 2027 * 37.2x
Enterprise Value 24.8B 21.67B 20B 18.43B 34.75B 2,388B 35.52B 239B 94.02B 1,170B 93.14B 91.1B 4,027B EV / Sales 2026 *
7.44x
EV / Sales 2027 * 6.95x
Free-Float
93.54%
Yield 2026 *
0.24%
Yield 2027 * 0.27%
1 day+0.32%
1 week+2.49%
Current month+2.57%
1 month+16.06%
1 week 287.59
Extreme 287.5875
294.02
1 month 264.33
Extreme 264.33
294.02
Current year 253.33
Extreme 253.329
294.02
1 year 253.33
Extreme 253.329
294.02
3 years 253.33
Extreme 253.329
294.02
5 years 253.33
Extreme 253.329
294.02
10 years 253.33
Extreme 253.329
294.02
Manager TitleAgeSince
Chief Executive Officer 56 2015-04-23
Director of Finance/CFO 57 2025-08-03
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 65 2011-01-31
Director/Board Member 69 2011-03-06
Director/Board Member 56 2012-02-11
Change 5-day change 1-year change 3-year change Capi.($)
+0.32%+2.49% - - 25.61B
+1.87%+7.19%-16.46%-5.91% 172B
-0.43%-0.80%-7.07%-4.05% 107B
-0.03%+1.47%+4.59%+60.25% 59.92B
+0.66%+0.96%+37.56%+53.38% 51.58B
-1.10%+4.10%-12.56%-38.37% 44.07B
-3.21%-3.05% - - 34.76B
-1.71%+2.25%-8.86%-44.23% 30.09B
-1.49%+0.85%-3.01%-4.60% 21.55B
-0.91%+1.31%-3.73%-18.94% 20.86B
Average -0.60%+1.64%-1.19%-0.31% 60.22B
Weighted average by Cap. +0.09%+2.78%-4.61%+2.76%

Financials

2026 *2027 *
Net sales 3.33B 2.91B 2.69B 2.48B 4.67B 321B 4.77B 32.12B 12.63B 157B 12.52B 12.24B 541B 3.54B 3.09B 2.85B 2.63B 4.96B 341B 5.07B 34.09B 13.41B 167B 13.28B 12.99B 574B
Net income 604M 528M 487M 449M 846M 58.18B 865M 5.82B 2.29B 28.5B 2.27B 2.22B 98.09B 686M 599M 553M 510M 961M 66.03B 982M 6.61B 2.6B 32.34B 2.57B 2.52B 111B
Net Debt -508M -444M -410M -378M -712M -48.93B -728M -4.9B -1.93B -23.96B -1.91B -1.87B -82.49B -741M -648M -598M -551M -1.04B -71.38B -1.06B -7.14B -2.81B -34.96B -2.78B -2.72B -120B
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - proprietary products (80.7%); - - contract-manufactured products (19.3%). At the end of 2024, the group had 21 production sites worldwide. Net sales are distributed geographically as follows: the United States (42.5%), Germany (12.9%), Ireland (11.2%), France (8.4%), Europe (13.3%) and other (11.7%).
Employees
10,800
Date Price Change
26-07-17 CHF 294.02 +0.32%
26-07-16 CHF 293.09 +1.91%
26-07-15 CHF 287.59 -0.31%
26-07-14 CHF 288.48 -0.43%
26-07-13 CHF 289.74 +1.00%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
358.24USD
Average target price
382.00USD
Spread / Average Target
+6.63%

Quarterly revenue - Rate of surprise